The FDA's treatment approval of Oxlumo™ (lumasiran) by Alnylam Pharmaceuticals is the first therapy for people with the rare genetic disease primary hyperoxaluria type 1 (PH1). Learn more about the drug approval on our blog. READ MORE >>

The patients who shared their stories at our UCKD Summit are shining examples of how undiagnosed or misdiagnosed causes of kidney disease directly impact care and outcomes. READ MORE >>

The KidneyX Innovation Accelerator announced Phase 1 of a new competition to push development of an artificial kidney toward human clinical trials. The goal is to focus on kidney replacements that will give patients options beyond dialysis. READ MORE >>

For individuals living with chronic kidney disease (CKD), advances in treatment offer significant hope for improved outcomes in slowing the disease’s progression and treating its comorbidities, especially cardiovascular disease. READ MORE >>

The top two causes of kidney disease are diabetes and high blood pressure, but many other things—including quite a few rare diseases—can also cause kidney disease and kidney failure. READ MORE >>

An experimental drug used to treat patients with lupus nephritis has successfully completed clinical trials and its maker will seek approval from the U.S. Food and Drug Administration in 2020. If approved, it would be the first drug approved to specifically treat lupus nephritis. READ MORE >>

For individuals living with diabetes—the leading cause of kidney failure—the approval by the U.S. Food and Drug Administration of the diabetes medicine canagliflozin (brand name INVOKANA®) to treat diabetic kidney disease and reduce the risk of hospitalization for heart failure patients with type 2 diabetes and diabetic kidney disease is cause for optimism. READ MORE >>

While seeking out information is an important part of being empowered to fight kidney disease, the internet is full of doubtful claims and outright false information. Separating fact from fiction—and understanding that supplements and alternative drugs can interact with prescribed drugs or cause harm in other ways—is especially important for kidney patients. READ MORE >>

Researchers who reviewed 74 studies conducted over 28 years on a widely used environmental pollutant have found evidence that the chemicals may contribute to poor kidney health. READ MORE >>

Following the rigorous treatment regimen for kidney failure, day after day, is challenging for patients. Our survey of patients and renal professionals provides insights—including the outsized role that depression plays. READ MORE >>

Great news for PKD patients: For the first time, there is a treatment for autosomal dominant polycystic kidney disease (ADPKD). READ MORE >>

Learn how investigators at Penn Medicine in Philadelphia have pioneered a new approach to grow the pool of organs for transplantation. READ MORE >>